Skip directly to content

Mutational Profiling and Cancer-Associated Thrombosis

Viernes, Agosto 20, 2021

Six mutations are associated with an increased risk for cancer-associated thrombosis, independent of cancer type.​

The etiology of cancer-associated thrombosis (CAT) is multifactorial, with influence from cancer stage, chemotherapy, postoperative state/immobility, prior thrombosis history, and presence of vascular access. 

 

 
Código de aprobación: PP-IMU-GLB-0151